Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Andrews

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|March 5, 1990
Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetateS Isonishi, P A Andrews, S B Howell
Transplantation Proceedings|March 27, 2001
Influence of donor/recipient size in living donor kidney transplantationP A Andrews, F Compton, C G Koffman
Cancer Chemotherapy and Pharmacology|January 1, 1997
The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cellsK M Mack, R G Canada, P A Andrews
Analytical Biochemistry|November 15, 1984
A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrateP A Andrews, W E Wung, S B Howell
Oncology Research|January 1, 1995
Inhibitors of intracellular pH regulation induce cisplatin resistance in EMT6 mouse mammary tumor cellsC M Laurencot, P A Andrews, K A Kennedy
Molecular Pharmacology|December 1, 1986
Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletionP A Andrews, M P Murphy, S B Howell
Cancer Chemotherapy and Pharmacology|January 1, 1990
Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B Howell
Anticancer Research|November 1, 1988
Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B Howell
Cancer Chemotherapy and Pharmacology|January 1, 1987
Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cellsP A Andrews, M P Murphy, S B Howell
BMJ (Clinical Research Ed.)|January 8, 1994
Renal disease and use of topical non-steroidal anti-inflammatory drugsC A O'Callaghan, P A Andrews, C S Ogg
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|March 5, 1990
Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetateS Isonishi, P A Andrews, S B Howell
Transplantation Proceedings|March 27, 2001
Influence of donor/recipient size in living donor kidney transplantationP A Andrews, F Compton, C G Koffman
Cancer Chemotherapy and Pharmacology|January 1, 1997
The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cellsK M Mack, R G Canada, P A Andrews
Analytical Biochemistry|November 15, 1984
A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrateP A Andrews, W E Wung, S B Howell
Oncology Research|January 1, 1995
Inhibitors of intracellular pH regulation induce cisplatin resistance in EMT6 mouse mammary tumor cellsC M Laurencot, P A Andrews, K A Kennedy
Molecular Pharmacology|December 1, 1986
Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletionP A Andrews, M P Murphy, S B Howell
Cancer Chemotherapy and Pharmacology|January 1, 1990
Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B Howell
Anticancer Research|November 1, 1988
Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B Howell
Cancer Chemotherapy and Pharmacology|January 1, 1987
Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cellsP A Andrews, M P Murphy, S B Howell
BMJ (Clinical Research Ed.)|January 8, 1994
Renal disease and use of topical non-steroidal anti-inflammatory drugsC A O'Callaghan, P A Andrews, C S Ogg
Pageof 13